← FDA Drug Approvals (Drugs@FDA)
METHYLPHENIDATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS ELIZABETH · Approved 2020-06-19
Drug application
- FDA Application #
ANDA210924- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METHYLPHENIDATE
- Generic name
- Methylphenidate
- Active ingredients
- METHYLPHENIDATE
- Dosage form
- TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACTAVIS ELIZABETH
- First approval
- 2020-06-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown